series-a
Stage
1
Investors
About
Dezima Pharma develops RNA-targeted therapies to treat metabolic and rare diseases by addressing their genetic underlying causes.
Explore Dezima Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.